Merck Licenses Bone Drug for Generic Sale
50296
Merck & Company said it had signed a deal for an authorized generic form of its blockbuster osteoporosis drug Fosamax to become available in February.
271543
The Food and Drug Administration strongly endorsed Biogen Idec Inc.'s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share. The drug, formerly called Antegren but renamed Tysabri, was developed with Elan Pharmaceuticals of Ireland. The FDA approved Tysabri for use on its own and in ...
288984
Spectrum Pharmaceuticals SPPI.O said  on Friday U.S. regulators have approved its generic version of  Bayer's BAYG.DE  Cipro antibiotic, triggering a $750,000  equity investment by one of its partners.
471781
The company is ready to handle competition from generics.
348744
Amgen has said that its experimental drug for osteoporosis increased bone density in women at least as well in a clinical trial as the widely prescribed Fosamax medicine from Merck.
738835
Merck & Co.  said on Thursday its $1.1 billion deal to buy Sirna Therapeutics Inc. cleared an antitrust hurdle and said the deal could close as early as the end of this month.
254545
An Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Merckâs generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt.
550498
German drug maker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for preventing  bone tumors in breast cancer patients.
738230
Genentech and OSI Pharmaceuticals won federal approval yesterday to sell Tarceva, a pill to treat lung cancer.
585414
Shares of Biovail Corp. fell Wednesday after the drug maker confirmed that a competitor had applied to the Food and Drug Administration to market a generic version of its extended-release antidepressant Wellbutrin XL.
762852
Mylan Laboratories Inc.  said on Tuesday it won U.S. approval for its generic versions of Pfizer Inc.'s  blockbuster anti-depressant Zoloft.
502454
The deal, which must be approved by regulators, will make the German group the number one generics company in Scandinavia, a growing market worth about 600m last year, according to Merck.
252163
A U.S. judge has granted a request from   Sanofi-Aventis and U.S. partner Bristol-Myers Squibb Co.   BMY.N to block the sale in the United States of a generic   form of its top selling blood-thinner Plavix, giving a boost to   shares in the French drugmaker on Friday.
109705
Tampa, Florida - If you or someone you know is taking the arthritis drug, Vioxx, itâs been pulled from the market. The manufacturer, Merck &amp; Co.
269171
Merck of Germany announced it would take control of Serono, a Swiss pharmaceutical maker, for 10.6 billion euros ($13.5 billion).
466090
Teva Pharmaceutical Industries, which makes generic drugs, has won American approval to sell the first copies of GlaxoSmithKlineÂs Zofran for nausea related to chemotherapy and surgical procedures. Shipment will begin immediately, Teva said in a statement. The brand-name versions of the injections had sales of $695 million in the 12 months that ended in September, Teva said, citing figures from IMS Health.
81672
The pharmaceutical giant is selling its pain relievers and other consumer products.